As of Jan 17
| -0.06 / -4.20%|
The 6 analysts offering 12-month price forecasts for Novavax Inc have a median target of 1.50, with a high estimate of 12.00 and a low estimate of 1.50. The median estimate represents a +9.49% increase from the last price of 1.37.
The current consensus among 8 polled investment analysts is to Hold stock in Novavax Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.